Pharmaceutical Analysis & Statistics in Oceania Countries, July 2013 (p5)

121-150 of about 200 reports

Purchase Reports From Reputable Market Research Publishers

Emergency Contraception in New Zealand

Emergency Contraception in New Zealand

  • $ 1 064
  • Industry report
  • July 2013
  • by Euromonitor International

Emergency contraception continued to be an acceptable medical method of preventing pregnancy within New Zealand during 2012. While abortion services are provided for free within New Zealand for permanent ...

  • Industries : Drug and Medication
  • Countries : New Zealand
Douglas Pharmaceuticals Ltd in Consumer Health (New Zealand)

Douglas Pharmaceuticals Ltd in Consumer Health (New Zealand)

  • $ 153
  • Company report
  • July 2013
  • by Euromonitor International

By focusing on low-volume high-value products, Douglas Pharmaceuticals continues to attract consumers and expand its operations. Douglas Pharmaceuticals focuses on generic as well as difficult to manufacture ...

  • Industries : Pharmaceutical
  • Countries : New Zealand
Mylan New Zealand Ltd in Consumer Health (New Zealand)

Mylan New Zealand Ltd in Consumer Health (New Zealand)

  • $ 153
  • Company report
  • July 2013
  • by Euromonitor International

Over the forecast period Mylan New Zealand Ltd will focus on its core business of manufacturing and distributing pharmaceutical prescription and OTC consumer health products. Euromonitor International ...

  • Industries : Healthcare, Pharmaceutical
  • Countries : New Zealand
Ear Care in New Zealand

Ear Care in New Zealand

  • $ 1 064
  • Industry report
  • July 2013
  • by Euromonitor International

Ear care value sales increased by 2% in 2012, which is lower than the 2011 growth of 33%. This is also compared with the current value review period CAGR of 8%. Higher growth in 2011 and over the review ...

  • Industries : Drug and Medication
  • Countries : New Zealand
ICT budget forecasts in Medium-sized New Zealand Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013

ICT budget forecasts in Medium-sized New Zealand Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013

  • $ 495
  • Industry report
  • July 2013
  • by Kable

Synopsis This report illustrates how Kable expects Medium-sized New Zealand Pharmaceutical Companies to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, ...

  • Industries : Pharmaceutical
  • Countries : New Zealand
ICT budget forecasts in Small New Zealand Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013

ICT budget forecasts in Small New Zealand Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013

  • $ 495
  • Industry report
  • July 2013
  • by Kable

Synopsis This report illustrates how Kable expects Small New Zealand Pharmaceutical Companies to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, IT ...

  • Industries : Pharmaceutical
  • Countries : New Zealand
ICT budget forecasts in Large New Zealand Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013

ICT budget forecasts in Large New Zealand Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013

  • $ 495
  • Industry report
  • July 2013
  • by Kable

Synopsis This report illustrates how Kable expects Large New Zealand Pharmaceutical Companies to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, IT ...

  • Industries : Pharmaceutical
  • Countries : New Zealand
ICT budget forecasts in Small Australian Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013

ICT budget forecasts in Small Australian Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013

  • $ 495
  • Industry report
  • July 2013
  • by Kable

Synopsis This report illustrates how Kable expects Small Australian Pharmaceutical Companies to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, IT services, ...

  • Industries : Pharmaceutical
  • Countries : Australia
ICT budget forecasts in Large Australian Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013

ICT budget forecasts in Large Australian Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013

  • $ 495
  • Industry report
  • July 2013
  • by Kable

Synopsis This report illustrates how Kable expects Large Australian Pharmaceutical Companies to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, IT services, ...

  • Industries : Pharmaceutical
  • Countries : Australia
ICT budget forecasts in Medium-sized Australian Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013

ICT budget forecasts in Medium-sized Australian Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013

  • $ 495
  • Industry report
  • July 2013
  • by Kable

Synopsis This report illustrates how Kable expects Medium-sized Australian Pharmaceutical Companies to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, ...

  • Industries : Pharmaceutical
  • Countries : Australia
Australian Pharmaceutical Industries Ltd in Retailing (Australia)

Australian Pharmaceutical Industries Ltd in Retailing (Australia)

  • $ 153
  • Company report
  • July 2013
  • by Euromonitor International

Australian Pharmaceutical Industries Ltd is planning for rapid expansion in Australia, with the aim of opening at least 400 Priceline stores by 2014. This target amounts to an expansion of up to 50% from ...

  • Industries : Pharmaceutical
  • Countries : Australia
iNova Pharmaceuticals (Australia) Pty Limited - Strategic SWOT Analysis Review

iNova Pharmaceuticals (Australia) Pty Limited - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • July 2013
  • by Global Data

Summary This comprehensive SWOT profile of iNova Pharmaceuticals (Australia) Pty Limited provides you with an in-depth strategic analysis of the company's businesses and operations. The profile will give ...

  • Countries : Australia
Australian Pharmaceutical Industries Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Australian Pharmaceutical Industries Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2013
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Pharmaceutical
  • Countries : Australia
New Zealand Pharmaceuticals Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

New Zealand Pharmaceuticals Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2013
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Pharmaceutical
  • Countries : New Zealand
Pharmacybrands Ltd in Retailing (New Zealand)

Pharmacybrands Ltd in Retailing (New Zealand)

  • $ 153
  • Company report
  • May 2013
  • by Euromonitor International

Pharmacybrands is expected to continue expanding its network of chemists/pharmacies across New Zealand through its five fascias; Amcal, Care Chemist, Radius Pharmacy, Life Pharmacy and Unichem. The company ...

  • Industries : Pharmacies and Drug Stores
  • Countries : New Zealand
EpiCast Report: Meningococcal Disease - Epidemiology Forecast to 2022

EpiCast Report: Meningococcal Disease - Epidemiology Forecast to 2022

  • $ 3 995
  • Industry report
  • May 2013
  • by Global Data

EpiCast Report: Meningococcal Disease - Epidemiology Forecast to 2022 Summary Meningococcal disease is caused by Neisseria meningitidis, which is an encapsulated, Gram-negative bacterium that has an incidence ...

  • Industries : Pathology
  • Countries : World, Spain, United Kingdom, Australia, Brazil
iNova Pharmaceuticals (Australia) Pty Ltd in Consumer Health (Australia)

iNova Pharmaceuticals (Australia) Pty Ltd in Consumer Health (Australia)

  • $ 153
  • Company report
  • March 2013
  • by Euromonitor International

iNova Pharmaceuticals (Australia) Pty Ltd is focusing on acquiring products and distribution rights to continue its expansion in Australia and in the export markets of New Zealand, the Asia-Pacific region ...

  • Industries : Pharmaceutical
  • Countries : Australia
Ear Care in Australia

Ear Care in Australia

  • $ 1 064
  • Industry report
  • March 2013
  • by Euromonitor International

Acute otitis media is an ear infection where ear care products are used to relieve pain, while the growing popularity of swimming and the subsequent incidence of swimmer’s ear represent a key drive ...

  • Industries : Drug and Medication
  • Countries : Australia
Emergency Contraception in Australia

Emergency Contraception in Australia

  • $ 1 064
  • Industry report
  • March 2013
  • by Euromonitor International

Emergency contraception is available in Australia. The product is Schedule 3, which means it can only be sold from behind the counter, involving interaction with a pharmacist. The emergency contraceptive ...

  • Industries : Healthcare
  • Countries : Australia
Healthcare, Regulatory and Reimbursement Landscape - New Zealand

Healthcare, Regulatory and Reimbursement Landscape - New Zealand

  • $ 1 995
  • Industry report
  • February 2013
  • by Global Data

Healthcare, Regulatory and Reimbursement Landscape - New Zealand Summary GlobalData, the industry analysis specialist, has released its new report, “Healthcare, Regulatory and Reimbursement Landscape ...

  • Industries : Pharmaceutical
  • Countries : New Zealand
Vitamins & Minerals – Australia (2012)

Vitamins & Minerals – Australia (2012)

  • $ 599
  • Industry report
  • December 2012
  • by Mintel

Vitamins & Minerals in Australia by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2012. This market covers single/dual, multi-vitamins and ...

  • Industries : Retail, Vitamin and Supplement, Vitamin and Supplement
  • Countries : Australia
ANZUS Drug Stores & Health & Beauty Stores  to 2016

ANZUS Drug Stores & Health & Beauty Stores to 2016

  • $ 250
  • Industry report
  • September 2012
  • by Canadean Ltd

Synopsis "ANZUS Drug Stores & Health & Beauty Stores to 2016" provides in-depth detail on the trends and drivers of the Drug Stores and Health and Beauty Stores market in the ANZUS region. The report ...

  • Industries : Pharmacies and Drug Stores, Pharmacies and Personal Care Stores, Specialty Stores
  • Countries : Australia, New Zealand, United States
Pharmaceutical Pricing and Reimbursement - Adoption of Health Technology Assessments (HTA) Optimizes Drug Pricing and Accelerates Reimbursement Decision-Making

Pharmaceutical Pricing and Reimbursement - Adoption of Health Technology Assessments (HTA) Optimizes Drug Pricing and Accelerates Reimbursement Decision-Making

  • $ 3 500
  • Industry report
  • September 2012
  • by GBI Research

Pharmaceutical Pricing and Reimbursement - Adoption of Health Technology Assessments (HTA) Optimizes Drug Pricing and Accelerates Reimbursement Decision-Making Summary GBI Research, leading business intelligence ...

  • Industries : Pharmaceutical, Healthcare, Managed Care
  • Countries : Australia
Sigma Pharmaceuticals Limited (SIP) : Company Profile and SWOT Analysis

Sigma Pharmaceuticals Limited (SIP) : Company Profile and SWOT Analysis

  • $ 125
  • Company report
  • July 2012
  • by World Market Intelligence Ltd

Synopsis World Market Intelligence's 'Sigma Pharmaceuticals Limited (SIP) : Company Profile and SWOT Analysis' contains in depth information and data about the company and its operations. The profile contains ...

  • Countries : Australia, World
Global Clinical Laboratory Testing Market Report: 2012 Edition

Global Clinical Laboratory Testing Market Report: 2012 Edition

  • $ 800
  • Industry report
  • June 2012
  • by Koncept Analytics

Clinical laboratory testing market is one of the prime segments of healthcare industry. The market for clinical laboratory testing has seen significant growth in the recent years and it is expected that ...

  • Industries : Diagnostics, Diagnostics, In Vitro Diagnostic, In Vitro Diagnostic, Pharmaceutical
  • Countries : Australia
OTC Pharmaceuticals – New Zealand (2011)

OTC Pharmaceuticals – New Zealand (2011)

  • $ 599
  • Industry report
  • April 2012
  • by Mintel

OTC Pharmaceuticals in New Zealand by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2011. This market covers OTC pharmaceuticals, that is, ...

  • Industries : Over-The-Counter Drug
  • Countries : New Zealand
Australian Pharmaceutical Industries Limited: Retailing Company Profile, SWOT & Financial Report

Australian Pharmaceutical Industries Limited: Retailing Company Profile, SWOT & Financial Report

  • $ 125
  • Company report
  • April 2012
  • by Canadean Ltd

Synopsis Canadean's "Australian Pharmaceutical Industries Limited: Retailing Company Profile, SWOT & Financial Report" contains in depth information and data about the company and its operations. The profile ...

  • Industries : Pharmaceutical
  • Countries : Australia
Chemical & Pharmaceutical Plant Construction in Australia to 2015: Market Snapshot, World Market Intelligence Ltd

Chemical & Pharmaceutical Plant Construction in Australia to 2015: Market Snapshot, World Market Intelligence Ltd

  • $ 75
  • Industry report
  • March 2012
  • by World Market Intelligence Ltd

Synopsis WMI's 'Chemical & Pharmaceutical Plant Construction in Australia to 2015: Market Snapshot' contains detailed historic and forecast construction market values for the overall category in which ...

  • Industries : Construction and Building, Pharmaceutical, Building and Engineering
  • Countries : Australia
Pharmaceuticals – Australia – (2011)

Pharmaceuticals – Australia – (2011)

  • $ 599
  • Industry report
  • February 2012
  • by Mintel

Pharmaceuticals in Australia by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2011. This market covers prescription and OTC pharmaceuticals. ...

  • Industries : Pharmaceutical
  • Countries : Australia
OTC Pharmaceuticals – Australia – (2011)

OTC Pharmaceuticals – Australia – (2011)

  • $ 599
  • Industry report
  • February 2012
  • by Mintel

OTC Pharmaceuticals in Australia by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2011. This market covers analgesics, cough/col/flu, gastro-intestinal, ...

  • Industries : Over-The-Counter Drug
  • Countries : Australia

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.